AVADEL PHARMACEUTICALS PLC — Director's Dealing 2016

Sep 9, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FLAMEL TECHNOLOGIES SA (FLML)
CIK: 0001012477
Period of Report: 2016-08-29

Reporting Person: Elrod Marcus W (VP, Sales)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$13.59	2026-08-10	ADSs (100000)		Direct

Footnotes

F1: Options become exercisable as to 25,000 ADSs on each of August 10, 2017, 2018, 2019 and 2020, provided that the reporting person continues to be employed by the issuer or an affiliate thereof.

F2: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs may be represented by American Depositary Receipts.